European Lobular Breast Cancer Consortium
@elbcc-2018.bsky.social
A multidisciplinary consortium to better understand lobular breast cancer and improve diagnosis and treatment. Founded in 2018 by Dr Patrick Derksen (UMC Utrecht). Current Chairs: Patrick Derksen, PhD; Christine Desmedt, PhD; Anne Salomon, MD PhD.
The Lobular Breast Cancer Alliance has joined Bluesky! Follow us here for information about the 2nd most common type of breast cancer, invasive lobular carcinoma (ILC). More coming soon! www.lobularbreastcancer.org
Lobular Breast Cancer Alliance (LBCA)
Patients, researchers and clinicians working together to advance research and promote better prevention, diagnosis, treatment and follow-up care for invasive lobular breast cancer (ILC).
lobularbreastcancer.org
Wonderful presentations from a truly inspiring #Lobular Breast Cancer Symposium 2024 in Leuven! Happy viewing! #CDH1 #ILC #TME #ImmunoILC #LOXL1 @elbcc-2018.bsky.social www.youtube.com/watch?v=g7IN... www.youtube.com/watch?v=g7IN... www.youtube.com/watch?v=P56x... www.youtube.com/watch?v=rOLa...
ILC Symposium 2024 - Day 1 - 9/23/2024
YouTube video by Invasive Lobular Breast Cancer (ILC) Symposium
youtube.com
Afadin is an #ILC #metastasis suppressor! Based on clinical and experimental data we show that Afadin inhibits metastasis by stabilizing the #E-cadherin to F-actin link. The α-catenin binding CC domains is key, not the F-actin binding region! pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/...
We have overhauled www.elbcc.org and ask all existing and future participants to register and indicate their preferred working groups. Check the site, current members, and spread the word! @christinedesmedt.bsky.social @pwbderksen.bsky.social @lobularbcuk.bsky.social @lobularbca.bsky.social
Interesting. Her2 mutant responders show co-occurrence with CDH1 mutations. www.nature.com/articles/s41...
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial - Nature Medicine
In this phase 2 basket trial, patients with heavily pretreated HER2-mutated metastatic breast cancer received the small-molecule HER2 inhibitor tucatinib and anti-HER2 trastuzumab, leading to encourag...
nature.com
ELBCC has joined the blue space! First post concerns the footage of the #ILCSymposium 2024, now on our YouTube channel youtube.com/@elbcc.europ...
ELBCC. European Lobular Breast Cancer Consortium
This is the channel of the European Lobular Breast Cancer Consortium (ELBCC). We started this consortium in November 2018 with the intention to develop a platform to bring together discovery scientis...
youtube.com